Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02913092 · ClinicalTrials.gov registry record · NA

Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients

A NA study of Asthma, sponsored by Montefiore Medical Center.

Completed
Registry status
NA
Development phase
81
Enrollment target
1
Study location

NCT02913092 is a NA study of Asthma that has completed, run by Montefiore Medical Center. The registered enrollment target is 81 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02913092, a NA study of Asthma, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the role of using electronic sensors for asthma inhaler devices in monitoring medication adherence and asthma control

Conditions Studied

Interventions

  • BEHAVIORAL Electronic sensor and OW education

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2017-05-17
Est. Completion 2022-05-23
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT02913092

The ClinicalTrials.gov registry entry for NCT02913092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (95% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Electronic sensor and OW education is the first listed.

NCT02913092 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02913092 about?

NCT02913092 is a clinical study titled "Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients". This study will evaluate the role of using electronic sensors for asthma inhaler devices in monitoring medication adherence and asthma control

What is the current status of trial NCT02913092?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2017-05-17. Estimated completion is 2022-05-23.

What conditions does trial NCT02913092 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT02913092?

The interventions under investigation include: Electronic sensor and OW education (BEHAVIORAL).

Who is sponsoring clinical trial NCT02913092?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02913092 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.